There was an Injectafer drug label change in February 2020 which added a new hypophosphatemia warning. Most importantly, the Warnings and Precautions part of the Injectafer drug label added a new subsection 5.2 titled “Symptomatic Hypophosphatemia”. Some background about the new hypophosphatemia warning for Injectafer can be found in these two … [Read more...]
Hypophosphatemia Associated With Injectafer Compared To Another Intravenous Anemia Drug
A February 2020 article published by the JAMA medical journal, “Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia — Two Randomized Clinical Trials”, reports on the rate of hypophosphatemia associated with Injectafer compared to another intravenous iron deficiency anemia drug called … [Read more...]
Hypophosphatemia Is An Injectafer Side Effect With Possible Serious Medical Complications Including Death
Injectafer-induced hypophosphatemia (HPP) is an Injectafer side effect causing muscle weakness, fatigue, and severe nausea. In turn, these hypophosphatemia symptoms can lead to Injectafer-related medical complications including osteomalacia, arrhythmias, cardiac arrest, respiratory failure, and rhabdomyolysis. Injectafer is one of several … [Read more...]